hsa-mir-3917: Hsa-mir-3917 is a microRNA that has been identified as a component of various diagnostic and prognostic signatures in different types of cancer, including stomach adenocarcinoma (STAD) and colon cancer (COAD) [PMC7772397] [PMC6856753] [PMC6120165] [PMC6937800]. In STAD, hsa-mir-3917 is part of a diagnostic signature that includes other microRNAs such as hsa-mir-509-2, hsa-mir-495, and hsa-mir-145, which may serve as independent biomarkers for overall survival [PMC6856753]. In COAD, the coefficient of hsa-mir-3917 is negative, indicating its protective effect against the disease [PMC6937800]. Additionally, hsa-mir-3917 has been found to be upregulated in chronic pancreatitis (CP) tissue compared to normal tissue [PMC7606899]. Furthermore, miRNAs such as hsa-miR-4697-3p have been reported to have potential roles in drug resistance and relapse in various types of cancer [PMC8777531]. Overall, the presence and expression levels of hsa-mir-3917 have been implicated in the diagnosis and prognosis of different types of cancer.